Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - artemether and lumefantrine - dispersible tablet - each uncoated tablet contains artemether 20 mg… - antimalarial antiprotozoals: aminoquinolines

Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - artemether lumefantrine - tablet - artemether 20mg lumefantrine 120mg - antimalarial antiprotozoals: combinations of

Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz emtricitabine tenofovir disoproxil… - tablet - efavirenz 600mg emtricitabine 200mg tenofovir… - antivirals for systemic use: combinations of

Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz usp - tablet - efavirenz 200mg - antivirals for systemic use: non-nucleoside

Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz usp - tablet - efavirenz 600mg - antivirals for systemic use: non-nucleoside

Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - lamivudine usp zidovudine usp - tablet - lamivudine 150 mg & zidovudine 300 mg - antivirals for systemic use: combinations of

Kenya - engelsk - Pharmacy and Poisons Board

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - tenofovir disoproxil fumarate - tablet - tenofovir disoproxil fumarate 300mg - antivirals for systemic use:

Zimbabwe - engelsk - Medicines Control Authority

strides pharma science limited - artemether; lumefantrine - tablet; oral - 80; 480mg

Zimbabwe - engelsk - Medicines Control Authority

strides pharma science limited - dolutegravir sodium - tablet, coated; oral - 50mg

USA - engelsk - NLM (National Library of Medicine)

strides pharma science limited - potassium chloride (unii: 660yq98i10) (chloride ion - unii:q32zn48698, potassium cation - unii:295o53k152) - potassium chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. potassium chloride is contraindicated in patients on potassium sparing diuretics. there are no human data related to use of potassium chloride during pregnancy, and animal studies have not been conducted. potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. the background risk for major birth defects and miscarriage in the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary the normal potassium ion content of human milk is about 13 meq per liter. since potassium from oral supplements such as